None declared. Source of funding: Bristol Urological Institute, UK.


  • 1
    Oesterlinck W, Lobel B, Jakse G, Malström PU, Stöckle M, Sternberg C. European Association of Urology (EAU) Working Group On Urological Oncology. Guidelines on bladder cancer. Eur Urol 2002; 4: 10512
  • 2
    Brausi M, Collette L, Kurth K et al. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol 2002; 41: 52331
  • 3
    Bressel M, Kemper K, Städtler F. Vorbedingungen und technik der transurethralen elektroresektion des harnblasenkarzinoms. Urologe A 1969; 8: 7380
  • 4
    Flamm J, Steiner R. Stellenwert der differenzierten transurethralen resektion beim primären oberflächlichen harnblasenkarzinom. Urologe A 1991; 30: 1113
  • 5
    Zaak D, Kriegmair M, Stepp H et al. Endoscopic detection of transitional cell carcinoma with 5-aminolevulinic acid: Results of 1012 fluorescence endoscopies. Urology 2001; 57: 6904
  • 6
    Kriegmair M, Zaak D, Rothenberger KH et al. Transurethral resection for bladder cancer using 5-aminolevulinic acid induced fluorescence endoscopy versus white light endoscopy. J Urol 2002; 168: 4758
  • 7
    Heney NM, Ahmed S, Flanagan MJ et al. Superficial bladder cancer. Progression and recurrence. J Urol 1983; 130: 10836
  • 8
    Wijkström H, Norming U, Lagerkvist M, Nilsson B, Näslund I, Wiklund P. Evaluation of clinical staging before cystectomy in transitional cell bladder carcinoma: a long-term follow-up of 276 consecutive patients. Br J Urol 1998; 81: 68691
  • 9
    Witjes JA, Keimeney LA, Schaafsma HE, Debruyne FM. The influence of review pathology on study outcome of a randomised multicenter superficial bladder cancer trial. Members of the Dutch South East Cooperative Urological Group. Br J Urol 1994; 73: 1726
  • 10
    Van Der Meijden A, Sylvester R, Collette L, Bono A, Ten Kate F. The role and impact of pathology review on the stage and grade assessment of stages Ta and T1 bladder tumours: a combined analysis of 5 EORTC trials for research and treatment of cancer trials. J Urol 2000; 164: 15337
  • 11
    Kurth K, Schroeder FH, Debruyne F et al. Long-term follow-up in superficial transitional cell carcinoma of the bladder: prognostic factors for time to first recurrence, recurrence rate, and survival. Final results of a randomized trial comparing doxorubicin hydrochloride, ethoglucid, and transurethral resection alone. EORTC Genitourinary Tract Cancer Cooperative Group. Prog Clin Biol Res 1989; 303: 48190
  • 12
    Klän R, Loy V, Hulland H. Residual tumour discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder. J Urol 1991; 146: 3168
  • 13
    Herr HW. The value of a second transurethral resection in evaluating patients with bladder tumors. J Urol 1999; 162: 746
  • 14
    Brauers A, Buettner R, Jakse G. Second resection and prognosis in primary high risk superficial bladder cancer. J Urol 2001; 165: 80810
  • 15
    Schwaibold H, Treiber U, Kübler H, Leyh H, Hartung R. Significance of second transurethral resection for T1 bladder cancer. Eur Urol 2000; 37 (Suppl. 2): A441
  • 16
    Schips L, Augustin H, Zigeuner R et al. Is repeat transurethral resection justified in patients with newly diagnosed superficial bladder cancer? Urology 2002; 59: 2203
  • 17
    Grimm MO, Steinhoff C, Simon X, Spiegelhalder P, Ackermann R, Vögeli TA. Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study. J Urol 2003; 170: 4337
  • 18
    Zurkirchen MA, Susler T, Gaspert A, Hauri D. Second transurethral resection of superficial transitional cell carcinoma of the bladder: a must even for experienced urologist. Urol Int 2004; 72: 99102
  • 19
    Vögeli TA, Grimm MO, Simon X, Ackermann R. Prospective study of effectiveness. Reoperation (re-TUR) in superficial bladder carcinoma. Urologe A 2002; 41: 4704
  • 20
    El-Abbady Shoukry MS, Hanno AG, Younis LK, Abdel-Rahman M. Repeated transurethral resection of recurrent superficial bladder tumors. Does it affect spread and stage of the tumour? Scan J Urol Nephrol 2002; 36: 602